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ABSTRACT 
Sutika is the stage as placenta out from the womb for 1st to 6th weeks. Sutika is the condition in 
which she had feeling of mother and due to this Prakrut vata helps to initiation of Breast milk 
secretion, for all this there is changes takes place in hormone, this all done by Prakrut vata dosha 
and balance of Kapha doshas. Shushrut mentioned Mudhagarbha in which Vipatan (incision) done 
by Vaidyas into uterus to take out baby from womb, after expulsion of placenta the lady is called 
Sutika (puerperial stage). Breast secretion were observed in post caesarian patient after 3-4 days, 
as baby not delivered by Prakrut prasava. The Ayurvedic formulation having property to provide 
stability to the mother in Sutika awstha, digestive Rasa dhatu and provide proper digestive milk 
nutrients to the baby for their proper growth and development. Galactogogues are substances 
used to induce, maintain, and increase milk production, both in humanclinical condition(like 
noninfectious agalactias and hypogalactias). Shatavari is a good herbal galactogogues which 
increase milk production after post caesarian section. 
Aim: To study the evaluation of Breast milk secretion with Ayurvedic formulations and to avoid 
modern medicines in post cesarian section cases side effects on breast secretion and use of antacid 
property of Shatvari kalpa. 
Methodology: Oral medication Shatavarikalpa were administered to the patient of post cesarian, 
after two days when shifted to oral diet for 1 month. Result: A total no. of 100 patients were 
included in this study out of which 50 patients were treated with Ayurvedic formulation and 50 
were treated with modern analgesics with antibiotics. In trial group on day 7th 41(82%) patients 
having good secretion and on day 15th 44 (88%) patients good secretion were observed. In control 
group on day 7th 31 (62%) patients having good secretion and on day 15th 35 (70%) patients were 
observed. Average duration of stay at the IPD was 7 days and follow upon 15th day. 
Conclusion: The administration of Shatavarikalpa helps in adequate milk secretion for neonate 
growth. This combination maybe an effective alternative for act as an antacid treatment 
administered to patients undergoing post caesarian section cases.  
KEYWORDS: Shatavarikalpa, Breast milk secretion, Post cesarian, Antacid. 
INTRODUCTION
 Ayurveda, the Indian system of medicine 
practiced today has its roots in the Vedic thinking. 
Ayurveda is one of the world oldest holistic (whole 
body) healing system1. The World Health 
Organization - WHO has estimated that major 
percentage of the population in developing countries 
depends primarily upon herbal medicine for basic 
health care. Ayurveda is one of the Indian traditional 
system which comprise herbal medicine. The 
traditional systems of medicine, commonly referred 
to as ‘Complementary and Alternative Medicine’ 
(CAM) are widely used and looked upon for possible 
and safe solutions to present day health and medical 
problems.2 Ayurveda follows its own unique 
philosophy and methodologies to address issues of 
health care.3, 4 
 Ayurveda, as usual being explicit, describes 
this condition as Sutika Avastha. That is even the 
corner stone of women's life, is also considered here. 
Of course Sutika is not a Rogi, the Paricharya 
explained to Sutika in Prasavottara Kaala is like 
Dinacharya, Ritucharya as explained for Swashta. 
There are ample changes occurring in Garbhavastha 
and Prasavastha. A Sutika’s Sharira is thought to be 
Shoonya-Sharira after delivery due to exertion of 
labour pains & excretion of moisture (Kleda) & 
blood.5 
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 Acharya Sushruta & Acharya Vagbhat6 has 
given it a time period of 1½ months/ until she 
restarts her menstrual cycle again. According to 
Acharya Kashyap, Sutika-Kaala is upto 6 months7 and 
Acharya Bhavprakash, is upto 4 months.  
 Charya Charaka has given a schedule of 8-9 
days in Ch. Sha. 8/48 for Sutika in which he has 
mentioned the management of early puerperium 
including Snehpana, Abhyanga, Udarveshtana, 
Yavagupana etc. by which he has indicated that early 
puerperium (Sadya-Prasutakaala) is the time period 
in which a Sutika needs extra special care until she 
returns to her normal physiology progressively. 
 Breast milk is uniquely superior for infant 
feeding. it is the normal food for infants from birth. It 
contains all of the essential nutrients, antibodies and 
other factor important for growth and development. 
Breast milk can be provided exclusively for around 
the first 6 months, meeting all of the infants 
nutritional needs. Breast milk is still very important 
beyond the first 6 months. Once complementary 
foods are introduced Breast milk continue to provide 
important nutrients and growth factor up to 2 
years..Breast milk also contains important non- 
nutritional components, such as antimicrobial factor 
that are important for passive protection against 
infections and immune mediated diseases and 
modulate immunological development. Providing 
Breast milk has many benefits to both the mother 
and infant. It contains all the nutrients the infants 
needs for proper growth and development, these 
nutrients includes proteins, fats, carbohydrates, 
minerals, vitamins and trace elements. Milk 
production is essential for optimal feeding of infants 
and has a direct impact on growth, development, and 
health in neonatal period. 
 Nutritive demand of a neonate completely 
depends on breast feeding. Inadequate breast feeding 
affects health of baby. Shatavari is proven herb for 
increasing lactation. The root extract of A. racemosus 
is prescribed in Ayurveda to increase milk secretion 
during lactation. Oral intake of Shatavari pasted with 
milk is useful in inadequate lactation.10 'Ricalex' 
tablets with Shatavari as content (Aphali 
pharmaceutical Ltd. Ahmednagar) has shown to 
increase milk production in females complaining of 
deficient milk secretion.11 Increased weight of the 
mammary glands was observed in weaning rats, 
when alcoholic extract of Shatavari was used as 
Systemic administration ailing with inhibited 
involution of lobulo-alveolar tissue and maintained 
milk secretion.12 Enhance milk output is reported in 
women complaining of scanty breast milk, on 5th day 
after delivery, treated with A. racemosus along with 
some other herbal substances in the form of a 
Commercial preparation, lactare (TTK Pharma, 
Chennai).13-14 
 Charak Samhita written by Charak and 
Ashtang Hridyam written by Vagbhata, the two main 
texts on Ayurvedic medicines, lists Asparagus 
racemosus as part of the formulas to treat disorders 
affecting women’s health. In modern Ayurvedic 
practices the roots of plant are considered to be 
effective as antispasmodic, appetizer, stomach tonic, 
aphrodisiac, galactogogue, astringent, antidiarhoeal, 
antidysentiric, laxative, anticancer, anti- 
inflammatory, blood purifier, antitubercular, 
antiepileptic and also in night blindness, kidney 
problems and in throat complaints. Further, it is 
mentioned as Medhya- the plants which increase 
intelligence and promote learning and memory and 
as Rasayana, the rejuvenator herbs which improves 
health by increasing immunity, vitality and 
resistance, imparting longevity as well as protection 
against stress. This herb is also mentioned as balya 
means a strength promoter, Stanyaa- galactogogue 
and Jeevaniya- an erythropoetic. 
 Herbal galactogogues have also properties to 
induce and produce milk production. in this study 
Shatavari is the drug which is used as a herbal 
galactogogues properties. It is used after post 
caesarian section cases. Galactogogues are synthetic 
or plants molecules used to induce, maintain, and 
increase milk production, which mediate complex 
processes involving interaction between physical and 
physiological factor. Among the most important 
factors are hormones such as prolactin. 
 Most common galactogogues for human use 
are metrochlopramide, dpmperidone, chlormazine 
and sulpiride. These galactogogues having significant 
side effects in mother dry mouth syndrome or 
hyposalivation, hythmia gastrointestinal disorders, 
cardiac arrlethargy, extrapyramidal symptoms such 
as hyperhidrosis, facial seborrhea, hypertention 
tremor. 
AIM 
To study the evaluation of Breast milk secretion, 
antacid and other benefits in Post Caesarian Section 
cases. 
OBJECTIVES 
• To study the effect of Shatavarikalpa on breast milk 
secretion. 
• To study the effect of antacid property and other 
various parameters of puerperium. 
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Materials  
Table 1: Shatavari kalpa 
1. Shatavari 
Acparagus 
racemosa 
Madhura, 
Tikta, Katu 
Katu Sheeta 
Tridosh 
shamak 
Vrushya, Dahashmak, 
Garbhasthapak, Stanayajanan 
2. Sarkara  Madhur Madhura Sheeta 
Vata-
pitta 
shamak 
Vrushyavajikaran, 
Vedanastahpana,  
Shothahara, Garbhahayasthapan 
3. Ela 
Eletharia 
cardemomum 
Katu Madhura Sheeta 
Tridosha
hara 
Mukhashodhan, Dahaprashamana 
Balaya, Anuloman 
METHODOLOGY 
1) Drugs Review 
 Group A- Shatavarikalpa with Antibiotics and other 
Ayurvedic formulations. 
Group B- Antibiotics, Anti- inflammatory, 
serratiopeptides and Antacids. 
2) Number of patients: Total - 100 
 Group A  - 50 
 Group B - 50 
 3) Selection Criteria 
Inclusion Criteria : 
 All patients will be of post caesarian section cases. 
 Patient will be taken of all gravida. 
 HIV, VDRL, and HBsAG should be negative. 
Exclusion Criteria 
 Patient is having PIH, GDM, CardiacDisorder, 
Anaemia 
 Patient is suffering from infection. 
 History of previous abdominal surgery. 
 HIV, VDRL, HBsAG positive 
Discontinous Criteria 
 Severe illness during study. 
 Development of any side effect. 
 If patient suffer from severe infection during 
study. 
 Gastritis 
 Pyrexia 
 Excessive wound discharge after dressing. 
Table 2: Management for first forty eight hours of Post Caesarian Section was IV Antibiotics with 
antacids and analgesics as patient was kept nil by mouth (NBM) Ayurvedic Drug 
Drugs  
Form 
Route  Dose  Anupana  Duration  
2nd Day Evening  
Shatavari Kalpa  Granules  Orally  10 gm. 12 hourly  Milk  15 days  
Table 3: Modern Drugs(no any other galactogouge) 
Drugs Route Dose Anupana Duration 
Tab. Ziprax 200 12hrly  Oral  200 mg. 12 hourly  water  5 days  
Tab. Emanzen-D (Seratiopeptidiase) 12 hrly  Oral  8 hourly  water  5 days  
Tab. Rantac 150 12hrly.  Oral  12 hourly  water  5 days  
Table 4: Duration of Study 
Particular 
Group 
Trial group Control group 
Number of Patients 50 50 
Route Oral Oral 
Place 
Bharati Vidyapeeth Ayurved Hospital. IPD 
of Prasuti and streerog department 
Bharati Vidya peeth Ayurved Hospital. 
IPD of Prasuti and streerog department 
Duration 
5 days in IPD & Ayurvedic formulations 
continue till 1 months 
5 days after shifted IRON/CAL 
Follow Up 15th day after caesarian in OPD 15th day after caesarian in OPD 
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Assessment Criteria 
Each patient was assessed for the following criteria:-  
1. Gravidity: This was assessed form history taken in 
case format report such as gravida, parity, abortion, 
miscarriage, IUD. 
2. Prakruti: This was assessed by the factors as 
mentioned in the case format report. 
3. Age: This was assessed by categorizing the 
different age group such as, from 18 to 25 years, 26 
to 33 years, 34 to 41 years. 
4. BP: This was monitored 6 hourly manly, from day 
one today seven and record was kept daily to rule out 
any side effects of the drugs. 
5. Pulse: This was monitored manually 6 hourly daily 
to rule out any side effects of the drugs. 
6. Agni (Digestive power): This was assessed by 
questioning the patients about their desire to take 
food and ability to digest the food and feeling hungry.  
Table 5: Gradations for assessment of Agni 
Grades Criteria 
Grade 1 
(Uttam) 
Feeling of hunger between 6 to 8 
hours 
Grade 2 
(Madhyam) 
Feeling of hunger between 8 to10 
hours 
Grade 
(Heena) 
Feeling of hunger more than 12 
hours 
7.Tongue: This was assessed by the presence of 
coating (i.e. Saam and Niraam) present on the tongue 
from day one today seven and on day fifteen. 
8.Uterine Involution: This was assessed in 
centimeter as above pubic symphysis from day one 
today seven and on day fifteen follow up. 
Table 6: Uterine Involution as per modem criteria 
Grades Rate of Involution in Cm. 
Day 1 To 3 2 – 3 Cm. 
Day 4 To 7 3 – 5 Cm. 
Day 15 Complete involution 
 The rate of involution of uterus was clinically 
assessed by noting the regression of fundal height in 
relation to pubic symphysis in cms. The 
measurements were taken carefully at fixed time. 
Bladder was emptied before and preferably the 
bowel too. The uterus was centralized and then the 
measurement was taken with tape. Sub involution, if 
any was mentioned. 
9. Breast Secretion: This was assessed as Fulfillment 
of baby’s daily nutritional needs from postpartum 
day one today seven and day fifteen. 
  
 
 
Table 7: Gradation of Breast secretion 
Grade  
Grade 0 No Secretions 
Grade 1 Fulfillment of baby’s nutritional needs 
on day one 
Grade 2 Fulfillment of baby’s nutritional needs 
on day two to three 
Grade 3 Fulfillment of baby’s nutritional needs 
on day four to seven 
10.Breast Engorgement: This was assessed by 
hardening of Breast, rise in local temperature from 
day one today seven. 
11.Lochial Discharge: a) Colour: This was assessed 
by the colour of discharge as red, pink and yellow on 
pad, from day one today seven and on day fifteen 
follow up. 
Table 8: Gradations for assessment of Lochial 
Discharge 
Grade Varna (colour) 
Grade 1 Red 
Grade 2 Pink 
Grade 3 Yellow 
b) Quantity: This was assessed by the numbr of pads 
used, from day one today seven and on day fifteen 
follow up. 
Table 9: Gradations for assessment of Quantity of 
Lochial discharge 
Grade No of pads / day 
1 1 pads 
2 2 pads 
3 3 or more pads 
12. Haemogram 
a) This was assessed by investigating the blood for 
haemoglobin, Pre Operative, Post operative day 
three and one day fifteen follow up. 
b) Leucocyte Count (WBC Count): This was assessed 
by investigating the blood for leucocyte count 
upto 15000/cumm and above 20000/cumm 
c) Platelets Count: This was assessed by 
investigating the blood for platelets count 
ranging from less than 1.5 lakhs/cumm, between 
1.5 lakhs/cumm to 5 lakhs/cumm. 
13.Bowel Opening: This was assessed by 
questioning the patient about defecation from day 
one today seven daily and advised suppository on 
day three if defecation absent till day three. 
14.Body Temperature: This was assessed through 
Thermometer by measuring Body Temperature 
(Axillary) daily from day one today seven. It was 
assessed, as 96 degree to 98 degree and above 99 
degree. 
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Observations and Statistical Analysis 
Table 10: Breast secretions 
Breast 
Secretion 
Median Wilcoxon 
Signed Rank W 
P-
Value 
% Effect Result 
Day 1 Day 15 
Trial Group 3.0 1.0 -4.388a 0.005 75.3 Highly Significant 
Control Group 2.0 1.0 -4.400a 0.021 63.2 Significant 
Using one tailed Wilcoxon signed rank test, to test the hypothesis – 
H0 : Median improved Breast Secretion before and after treatment is zero or less. 
H1 : Median improved Breast secretion before and after treatment is greater than zero. 
 For trial group, the median improved Breast secretion before treatment and after treatment is highly 
significant (P-value = 0.005) at 5% level of significance. 
 For Control group, the median improved Breast Secretion before treatment and after treatment is 
significant (P-value = 0.021) at 5% level of significance. 
Table 11: Trial group considered as more effective as compared to control for breast secretion 
Breast 
Secretion 
Trial Group Control Group 
Grade 0 Grade 1 Grade 2 Grade 3 Grade 0 Grade 1 Grade 2 Grade 3 
Day 1 30 20 0 0 13 37 0 0 
Day 2 1 41 8 0 12 34 4 0 
Day 3 0 26 24 0 1 28 21 0 
Day 4 0 2 48 0 0 12 35 3 
Day 5 0 0 10 40 0 3 40 7 
Day 6 0 0 8 42 0 2 25 23 
Day 7 0 0 6 44 0 2 17 31 
Day 15 0 0 9 41 0 2 13 35 
         Graph : Breast secretions 
 
 In trial group on day 7th 41(82%) patients having good secretion and on day 15th 44 (88%) patients good 
secretion were observed. 
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 In control group on day 7th 31(62%) patients having good secretion and on day 15th 35 (70%) patients were 
observed. 
Table 12: Agni (digestive power) 
Agni 
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
Day 1 Day 7 
Trial Group 3.0 1.0 -2.935a 0.003 75.3 Significant 
Control Group 3.0 3.0 -1.890a 0.059 23.1 NS 
Using one tailed Wilcoxon signed rank test, to test the hypothesis – 
H0 : Median increase in Digestive power before and after treatment is zero or less. 
H1 : Median increase in Digestive power before and after treatment is greater than zero. 
For, the median increase in Digestive power before treatment and after treatment is significant (P-value < 
0.003) at 5% level of significance. i.e. it can be stated that, there is highly significant improvement in Digestive 
power in trial group. 
For group B, the median increase in Digestive power before treatment and after treatment is significant (P-
value < 0.059) at 5% level of significance. i.e. it can be stated that, there is significant improvement in Digestive 
power in Control group. 
 
Thus, it was observed that in Trial group.  
 Within 24 hours of treatment, 20 patients (40%) had Heenaagni (poor appetite), 19 patients (38%) had 
Madyam Agni (moderate appetite) &11 patients (22%) had Uttam agni (adequate appetite). 
 From second day remarkable Agni Deepan was observed till seventh day. 
 Till day seven of treatment, 12 patients (24%)had Heena agni, (poor appetite) 18 patients (36%) had 
Madyam agni (moderate appetite) and 20 patients (40%) had Prakrut (uttam) Agni (adequate appetite). 
Similarly in Control group 
 22 patients (44%) had Heena agni (poor appetite), 23 patients (46%) had Madyam agni (moderate 
appetite) &5 patients (10%) had Prakrut uttam agni (adequate appetite) in first 24 hours. 
 Till day seven, 25 patients (50%) had Heena agni (poor appetite)15 patients (30%) had Madyam agni 
(moderate appetite) and 10 patients (20%) had Prakrut (uttam) Agni (adequate appetite). 
Thus it is seen that in trial group Agni Deepan was enhanced from second day of treatment. It was not 
significant in control group. 
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Table 13: Uterine involution 
Uterine 
Involution 
Median Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
Day 1 Day 15 
Trial Group 2.0 1.0 -4.602a 0.000 68.7 Significant 
Control Group 2.0 1.0 -4.966a 0.000 62.3 Significant 
Using one tailed paired t test, to test the hypothesis – 
H0 : Mean reduction in Uterine involution before and after treatment is zero or less. 
H1 : Mean reduction in Uterine involution before and after treatment is greater than zero. 
For Trial group, the mean reduction in Uterine involution before treatment and after treatment is significant (P-
value < 0.00) at 5% level of significance. i.e. it can be stated that, there is significant Uterine involution observed 
in Trial group. 
For Control group, the mean reduction in Uterine involution before treatment and after treatment is significant 
(P-value <0.00) at 5% level of significance. i.e. it can be stated that, there is significant Uterine involution 
observed in Control group. 
Table 14: Significant Uterine involution observed in Trial Group and Control group 
Uterine Involution 
Trial Group 
(in cm above pubic symphysis) 
Control Group 
(in cm above pubic symphysis) 
Day 1 11.2 10.8 
Day 2 11.0 10.7 
Day 3 10.2 10.4 
Day 4 9.8 9.7 
Day 5 9.3 9.5 
Day 6 8.9 9.2 
Day 7 8.6 8.9 
Day 15 7.8 8.5 
Graph : Uterine involution 
 
In trial group, on day 1st average uterine involution 11.7cm (in cm above pubic symphysis) were observed and 
after treatment on day 7, average 8.6cm and on day 15th average uterine involution 8.5cmwere observed. 
In trial group, on day 1st average uterine involution 10.8cm(in cm above pubic symphysis) were observed and 
after treatment on day 7, average 8.9cm and on day 15th average uterine involution 8.5cmwere observed. 
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In control group on day 1st10(20%) having Saam jivha and on day 7th 7(14%) patients and on day 15th 7(14%) 
patientsand40(80%) having Niraam jivha and on day 7th 43(86%) patients and on day 15th 43 (86%) patients 
were observed. 
Table 14: Tongue observation (Jivha) 
Tongue Examination 
Trial Group Control Group 
Absent Present Absent Present 
Day 1 40 10 40 10 
Day 2 40 10 38 12 
Day 3 39 11 38 12 
Day 4 42 8 40 10 
Day 5 42 8 43 7 
Day 6 45 5 46 4 
Day 7 45 5 43 7 
Day 15 48 2 43 7 
Graph : Tongue observation (Jivha) 
 
In trial group on day 1st10(20%) having Saam jivha and on day 7th 5(10%) patients and on day 15th 2 (4%) 
patients and on day 1st 40(80%) having Niraam jivha and on day 7th 45(90%) patients and on day 15th 48 
(96%) patients were observed. 
In control group on day 1st10(20%) having Saam jivha and on day 7th 7(14%) patients and on day 15th 7(14%) 
patientsand40(80%) having Niraam jivha and on day 7th 43(86%) patients and on day 15th 43 (86%) patients 
were observed. 
Bowel opening (Malapravrutti) 
Stool Pass Trial Control 
With Suppository 8 40 
Without Suppository 42 10 
 
 
 
 
0
10
20
30
40
50
60
No Yes No Yes
Trial Group Control Group
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6
Day 7
Day 15
Int. J. Ayur. Pharma Research, 2017;5(12):22-32 
     Available online at: http://ijapr.in  30 
Graph 19 : Bowel opening (Malapravrutti) 
 
 In trial group out of 50 patients, bowel opened in 8 patients (16%) with suppository and 42 patients (84%) 
without suppository after treatment on day three was significant. 
 In Control group out of 50 patients, bowel opened in 40 patients (80%) with suppository and 10 patients 
(20%) without suppository after treatment on day three was not significant. 
Thus, trial group can be considered as more effective as compared control group drug which shown that 
trial group drug also act on bowel motility. 
6. Haemoglobin 
Hb% Examination 
Mean 
t-Value P-Value Result 
BT AT 
Trial Group 11.6 11.1 4.923 0.000 Significant 
Control Group 11.8 11.0 6.604 0.000 Significant 
Using one tailed paired t test, to test the hypothesis – 
H0 : Mean maintenance in Haemoglobin before and after treatment of post operative is zero or less. 
H1 : Mean maintenance in Haemoglobin before and after treatment of post operative is greater than zero. 
For trial group, the mean maintenance in a before treatment and after treatment is significant (P-value < 0.000) 
at 5% level of significance. i.e. it can be stated that, there is significant maintenance in Haemoglobin inspite of 
not given any haematanic. 
For Control group, the mean maintenance in Haeoglobin before treatment and after treatment is significant (P-
value < 0.000) at 5% level of significance. i.e. it can be stated that, there is significant maintenance in 
Haemoglobin inspite of given haematanic for 1 month. 
HB% Examination Trial Group Control Group 
Day 1 11.6 11.8 
Day 3 10.8 10.8 
Day 15 11.1 10.9 
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In Trial group, average Haemoglobin percentage before surgery was 11.6 gms%, on day three it was 10.8 gms% 
and on day fifteen it was 11.1gms%. 
In Control group, average Haemoglobin percentage before surgery was 11.8gms%, on day three it was 
10.8gms% and day fifteen it was 10.9gms%. 
DISCUSSION 
Integrated management in post caesarian 
section cases was observed effective in this study. 
This management is not an easy task. Ayurvedic 
formulation have shown their great result on various 
parameters observed.  
All patients tolerated these Ayurvedic formulations 
very well. 
Random selection of patients done for this 
study. All types of Prakruti’s were observed. But most 
of them were of Vata-Pitta & Kapha-Pitta prakruti in 
both groups. 
Involution is the process by which the uterus 
is transformed from pregnant to non pregnant state. 
It is a physiological process occurring after 
parturitions, the hypertrophy of the uterus has to be 
undone since it does not need to house the fetus 
anymore. Delayed decrease in size of the uterine 
height indicated infection. 
Uterine involution is a physiological process. 
It cannot be suppressed by any means. A good action 
found in uterine involution as it act as a Garbhashaya 
sodhaka action.  
 Shatavari has more than 50 organic 
compounds including steroidal saponins, glycosides, 
alkaloids, polysaccharides, mucilage, racemosol and 
isoflavones which are responsible for the multiple 
medicinal properties exhibited by the herb. 
 Shatavari is one of great rejuvenating and 
restorative herbs used in Ayurveda. According to 
Ayurveda, there are three vital energies or Doshas in 
the body known as Vata, Pitta, and Kapha. These 
three Doshas are delicately balanced in a unique 
proportion in every individual. Good health can be 
enjoyed only when this balance is maintained. 
Shatavari has proved to be extremely effective in 
restoring the balance of the Pitta dosha,  
Breast Milk Secretion is very important for 
neonatal nourishment. Shatavari have Madhura and 
Sheeta guna which help in milk production. An 
ancient texts Sushrut and Charak Samhitas 
mentioned Shatavari is Stanyajanan. It increases milk 
production. It has phytoestrogenic properties which 
help in hyperplasia in aleolar tissues and acini and 
increases milk production. 
According to chemical ingredients of 
Shatavari, it act as galactogouge. Shatavari roots 
reveals the presence of steroidal saponins (as 
Shatavari I-II) in which have estrogenic activity result 
from hormone and primary role seems to be 
potentiation of PRL production. 
 Shatavari is used in Ayurveda for dyspepsia 
(Amlapitta or acid regurgitation) and to increase milk 
secretion in a lactating woman. as its major 
component, has been reported to cause significant 
rise in scrum prolactin levels. The alcoholic extract 
of Asparagus racemosus has been shown to increase 
the prolactin levels in female. Dopamine released 
within the walls of the stomach as an endogenous 
neurotransmitter is known to impede gastric 
emptying. 
The present study was undertaken as a part 
of a project to identify indigenous drugs with 
antidopaminergic activity. The dried root of 
Shatavari is used in Ayurveda for both relief of 
Amlapitta and Shoola (dyspepsia) and to increase 
milk yield in lactating women. 
We found that the effect of Shatavari on 
gastric emptying was comparable with metoclo-
pramide, and its traditional use in dyspepsia may be 
justifiable. The usefulness of any potential anti-
dyspeptic drug may therefore possibly be predicted 
from its effect on gastric emptying]. As Shatavari 
accelerates gastric emptying rate, further studies are 
in progress in dyspepsia patients. The present study 
proved the mechanism of action of Shatavari. 
Maintenance of body temperature within 
normal limit is a sign of health. Ayurvedic 
formulations proved to be equally potent in 
maintaining health. 
Lochial discharge is outcome of physiological 
process after delivery. Shedding of deciduas is a 
physiological process, it was found in trial group pink 
color was found early on pads as compared to control 
group. This may be due to Ayurvedic formulations 
which is having good Garbhashaya shodhak action. 
So, it acts and shedding entire decidual surface.  
Haemoglobin levels were maintained in both 
groups inspite of iron supplementation in modern 
medicine group. Saubhagya shunthi pak contains 
Jaggary which is reach in non heam iron. Ayurvedic 
formulations were continued in trial group till one 
month after delivery & hemoglobin was recorded on 
fifteenth day. Nutritionists quotes that ten gm of 
jaggary contain 3% iron of daily value & it can used to 
support other medicine & dietary components for 
increasing haemoglobin level. 
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 Bowels were opened naturally without 
laxatives in Ayurvedic formulations group. This is 
achieved due to improved digestive power by those 
combinations. Ayurvedic formulations have property 
of Katu katu ushna guna and act as a Deepan pachana 
and Shatavari kalpa acts as a laxatives by its Madhura 
and Sheeta viryatmaka dravya. Ayurvedic texts 
mentioned that these drugs have potent action which 
leads to Agnivardhan. 
CONCLUSION 
Integrated management is the different 
approach which was taken as, an effort to develop 
amalgation effect in post operative in obstetrics. This 
study has been done to avoid some side effects of 
modern medicines and also act to overcome all 
factors of puerperium like Agni Mandya, Dhatu Kshya 
Janya Vata prakopa, Stanja Janan etc. 
Breast secretions is highly significant in Trial group 
than in Control group, as Shatavari is good 
Galactogouge action. 
Bowel Opening is more significant in Trial group than 
in Control group as it was without laxatives. 
Uterine involution and Lochial discharge, both are 
physiological process, it resulted according to 
physiology. 
Thus, it can be concluded, Ayurvedic Formulations 
proved to be choice of management for Post 
Caesarian patients. 
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